An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

A blood test that can detect a number of deadly cancers before symptoms develop is being trialled for potential use on the ...

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

New technologies are emerging that utilize artificial microRNA (miRNA) target sites to exploit or inhibit endogenous miRNA regulation. This approach has been used to improve cell-specific ...

Speaking at a research lab renamed after Dame Deborah, the Health Secretary said her 'inspirational' podcast helped him through his cancer diagnosis. | ITV National News ...

More than 44,000 people are diagnosed with bowel cancer every year, or about 120 every day. The disease is one of the most ...

Research suggests the test, known as miONCO-Dx, can detect 12 cancers at an early stage with 99% accuracy. However, a larger ...

Researchers from Voyager Therapeutics Inc. presented preclinical activity data of VY-1706, a blood-brain barrier (BBB)-penetrant gene therapy comprising an adeno-associated virus serotype 9 capsid ...

Cross-kingdom regulation and microRNA, to “bee” or not to be ... Very recently, Nanjing University has established the Institute of Artificial Intelligence Biomedicine, a big data-empowered ...

The Urine microRNA Purification Kit for Norgen allows for the fast and phenol-free purification of microRNA from urine samples. The Urine microRNA Purification Kit from Norgen offers a quick way ...

Victor Ambros and Gary Ruvkun won this year’s Physiology or Medicine award for the discovery of microRNA and its role in post-transcriptional gene regulation. Danielle is a Senior Editor at The ...